Source - SMW
PureTech Health said affiliate company Vedanta Biosciences had been issued with four new patents by the US Patent and Trademark Office.

The patents broadly cover compositions of matter and methods of use for therapeutic products, including mixtures of bacterial strains and spore-forming fractions based on beneficial bacteria, PureTech said.

They broaden the coverage for several programmes in Vedanta's clinical-stage pipeline, including the lead investigational product candidate, VE303, and further strengthen Vedanta's intellectual property position in the microbiome field, it added.

At 10:02am: (LON:PRTC) PureTech Health Plc share price was -2p at 142p